Navigation Links
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Date:10/1/2013

the same price that was paid in the tender offer (eligible shares exclude those for which holders properly demanded appraisal under Delaware law and those held by Amgen or Onyx or their respective wholly owned subsidiaries). Following completion of the merger, Onyx shares will cease to be traded on the NASDAQ Global Market, which is expected to take effect later today.

About Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward Looking Statements

This news release contains forward-looking statements that are based on Amgen's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described.  All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements about the planned completion of the tender offer and the merger, estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbit
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
2. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
3. Amgen To Participate At Citis 8th Annual Biotech Conference
4. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
5. Amgen to Highlight New Data at Upcoming ESC Congress 2013
6. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
7. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
8. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
9. Amgens Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
10. Amgen Announces Webcast of 2013 Second Quarter Financial Results
11. Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ... focused on the development of oral drug delivery ... of Spain has granted ... and Compositions for Oral Administrations of Proteins." ... is a technology pioneer in the field of ...
(Date:8/19/2014)... 19, 2014 Research and Markets has ... Strategic Business Report" report to their offering. ... in US$ Thousands by the following three major Application Areas: ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
(Date:8/18/2014)... August 19, 2014 Elbit Imaging ... EMITF ) announced today that Elbit Medical Technologies Ltd. ... in which it holds approximately 86% of the voting ... Ltd., in which Elbit Medical holds approximately 30.8% of ... of Gamida Cell,s shareholders (including Elbit Medical), signed Option ...
Breaking Medicine Technology:Oramed Granted Patent in Spain for Oral Administration of Insulin 2Oramed Granted Patent in Spain for Oral Administration of Insulin 3Global Anti-Adhesion Products - Strategic Business Report 2014 2Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 3
... 23 Kensey Nash Corporation (Nasdaq: KNSY ), ... a wide range of medical procedures, today reported the results ... 2010.   Fourth Quarter Snapshot and Recent ... the quarter, exceeding the high end of the Company,s previous ...
... 23 Uroplasty, Inc. (Nasdaq: UPI ... and markets innovative proprietary products to treat voiding ... and Palmetto GBA, South Carolina, both regional Medicare ... (PTNS) using the Urgent® PC Neuromodulation System for ...
Cached Medicine Technology:Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 2Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 3Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 4Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 5Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 6Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 7Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 8Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 9Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 10Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 11Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 12Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 13Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2010 Financial Results 14Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 2Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplasty's Urgent® PC Neuromodulation System 3
(Date:8/19/2014)... Merrick, NY (PRWEB) August 19, 2014 In honor ... helping you care for your old furry friend by offering tips ... to rely on their owners more. Because of this, dog owners ... for them. , As dogs age, their needs change. They will ... outside as much as they used to. Because of this, pet ...
(Date:8/19/2014)... Following the completion of a $16 million rooms ... is proud to debut the highly anticipated final phase of ... revamp of all public spaces to match the fresh look ... all-new dining experience at 1823 Kitchen and Bar and an ... introduction of 1823 Kitchen and Bar, Grand Hyatt Tampa Bay ...
(Date:8/19/2014)... cannot smoke during their stay and could use this time ... stay smoke-free after returning home. Now a study published ... a program that increased the proportion of hospitalized smokers who ... The system used interactive voice response technology automated ... three months after smokers left the hospital. , ...
(Date:8/19/2014)... 2014 Warfarin, the longtime standard treatment for ... in the anticoagulant drug marketplace including dabigatran, rivaroxaban, ... adoption of these novel oral anticoagulants (NOACs) into ... of all new anticoagulant prescriptions yet this represents ... published in The American Journal of Medicine ...
(Date:8/19/2014)... York, New York (PRWEB) August 19, 2014 ... U.S. courts, Bernstein Liebhard LLP notes the publication of ... antipsychotic medications may increase the risk of acute kidney ... by The Ottawa Citizen, the study was conducted by ... Ont., and the Institute for Clinical Evaluative Sciences, and ...
Breaking Medicine News(10 mins):Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3Health News:As Risperdal Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Linking Atypical Antipsychotic Medications to Kidney Damage in Elderly Patients 2Health News:As Risperdal Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Linking Atypical Antipsychotic Medications to Kidney Damage in Elderly Patients 3Health News:As Risperdal Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Linking Atypical Antipsychotic Medications to Kidney Damage in Elderly Patients 4
... Grubb & Ellis Healthcare,REIT, Inc. today announced the acquisition ... 5550 South East St., Epler Parke Building B is ... square feet of gross leaseable area., Built in ... offers 196 parking spaces and is accessible by Interstates ...
... Iomai Corporation,(Nasdaq: IOMI ) today announced, ... audit report included in the Company,s Annual,Report on ... Commission on,March 27, 2008 for the fiscal year ... This disclosure is required under NASDAQ,marketplace rules and ...
... ULURU Inc. (Amex:,ULU) today announced that it has scheduled ... results and provide a general business update,on Tuesday, April ... participate in the conference call, please dial (800) 357-0498 ... to ten,minutes prior to the initiation of the teleconference. ...
... Conn., March 28 Darwin,Professional Underwriters, Inc. ... the,resignation of Paul F. Romano, who served ... Thursday, March 27th. Mr. Romano has become,associated ... the,Hartford area., (Logo: http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ...
... suffers collateral damage from blood sugar disease , , FRIDAY, ... cause of heart disease, stroke, blindness, kidney failure and ... quicker than they normally do with age, a new ... in lung function as they grow older, research published ...
... With the full House and,Senate poised to ... Relief,(PEPFAR) reauthorization bill, a five-year, $50 billion initiative ... address,the critical HIV prevention shortfalls in the bill., ... to anti-retroviral drugs,(ARVs) since PEPFAR was enacted in ...
Cached Medicine News:Health News:Grubb & Ellis Healthcare REIT Acquires Epler Parke Building B in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Epler Parke Building B in Indianapolis 3Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update 2Health News:Darwin Announces Departure of Senior Vice President 2Health News:Lung Capacity Declines Faster With Diabetes 2Health News:Lung Capacity Declines Faster With Diabetes 3Health News:Will Congress Do More for HIV Prevention? 2Health News:Will Congress Do More for HIV Prevention? 3Health News:Will Congress Do More for HIV Prevention? 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: